Drug

D0987 | mepartricin

Molecular Formula C60H88N2O19
Molecular Weight 1141.3
Structure

G

A

D

G04CX03 Mepartricin


[G04CX] Other drugs used in benign prostatic hypertrophy


[G04C] DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY


[G04] UROLOGICALS


[G] Genitourinary system and reproductive hormones


G01AA09 Mepartricin


[G01AA] Antibiotics


[G01A] ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS


[G01] GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS


[G] Genitourinary system and reproductive hormones


D01AA06 Mepartricin


[D01AA] Antibiotics


[D01A] ANTIFUNGALS FOR TOPICAL USE


[D01] ANTIFUNGALS FOR DERMATOLOGICAL USE


[D] Dermatological drugs


A01AB16 Mepartricin


[A01AB] Antiinfectives and antiseptics for local oral treatment


[A01A] STOMATOLOGICAL PREPARATIONS


[A01] STOMATOLOGICAL PREPARATIONS


[A] Alimentary tract and metabolism


Toxicity Dose Time Species Model Method Action Positive criterion Reference
MEMBRANE POTENTIAL 23.16±6.59 human qHTS-HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 6.9 human HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 27.66±4.48 rat hepatocytes MMP assay decrease IC50 163


  • DrugBank Name mepartricin
    DrugBank DB13633
    CAS Number 11121-32-7, 62534-68-3
    PubChem Compound 9941647
    KEGG Drug D04921